Business Wire (Wed, 27-May 8:35 AM ET)
Globe Newswire (Wed, 20-May 8:00 AM ET)
IBN Initiates Coverage of Cardio Diagnostics Holdings Inc.
Globe Newswire (Wed, 8-Apr 8:30 AM ET)
Cardio Diagnostics Expands with Landmark PrecisionCHD Partnership in India
Market Chameleon (Wed, 7-Jan 2:31 AM ET)
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Cardio Diagnostics Hldgs trades on the NASDAQ stock market under the symbol CDIO.
As of June 11, 2026, CDIO stock price climbed to $2.03 with 23,872 million shares trading.
CDIO has a beta of 3.26, meaning it tends to be more sensitive to market movements. CDIO has a correlation of 0.06 to the broad based SPY ETF.
CDIO has a market cap of $6.01 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, CDIO traded as high as $106.80 and as low as $.97.
The top ETF exchange traded funds that CDIO belongs to (by Net Assets): VXF.
CDIO has underperformed the market in the last year with a return of -55.2%, while the SPY ETF gained +23.6%. In the last 3 month period, CDIO fell short of the market, returning -59.3%, while SPY returned +9.3%. However, in the most recent 2 weeks CDIO has outperformed the stock market by returning +16.0%, while SPY returned -1.6%.
CDIO support price is $1.78 and resistance is $2.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CDIO shares will trade within this expected range on the day.